BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).

A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

ANP-390 is under clinical development by AlphaNavi Pharma and currently in Phase I for Peripheral Neuropathic Pain.

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

A pinched nerve can interfere with your daily life, causing pain, numbness, and significant discomfort. It often occurs when ...

Physical therapy strengthens muscles and improves flexibility, while injection-based therapies reduce inflammation and block ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) said it submitted an Investigational New Drug (IND) application to the FDA to start ...

Thermal energy targets areas containing nerves that are responsible for transmitting or regulating the sensation of pain.

Professor Kim Jung-soo of the Department of Anesthesiology Pain Medicine at Seoul National University Hospital won the '2024 ...

Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the ...